Share

Slightly Elevated TSH Levels Not a Cause for Referral to Pediatric Endocrinologists

Children with thyroid stimulating hormone (TSH) levels slightly above reference range shouldn’t be referred to pediatric endocrinologists unless there is another cause for clinical concern, according to a paper recently published in the Journal of the Endocrine Society. Researchers led by Perrin C. White, MD, of the Division of Pediatric Endocrinology at the University of...
Share

E-cigarette Use during Pregnancy Impairs Metabolic Health in Daughters, Mouse Study Finds

E-cigarette usage may impair fertility and pregnancy outcomes, according to a mouse study published in the Journal of the Endocrine Society. Researchers led by Kathleen Caron, PhD, of University of North Carolina at Chapel Hill, N.C., point out that while the dangers of cigarette smoke are well established, the England Public Health system has ruled e-cigarettes...
Share

Endocrine Society Urges Policy Makers to Follow Science on Transgender Health

Texas custody case prompts unfounded claims. A custody case in Texas has sparked heated debate and embroiled state policy makers in public discussions about the diagnosis and appropriate medical treatment of transgender children. Unfortunately, many of the claims being made about gender-affirming care for transgender and gender-incongruent individuals are inaccurate. Policies concerning the diagnosis and...
Share

A New Normal: The Quest for Age-Related Reference Ranges for Children

A lack of accurate reference standards can often prove challenging when it comes to treating pediatric patients. A coalition is seeking a federal effort to establish better pediatric reference intervals for medical tests could make treating these patients less problematic.    “Children are not small adults” is an admonition to remind clinicians that they should...
Share

Takeda Announces NATPARA Special Use Program in the U.S.

In the wake of the recall of hypoparathyroidism drug NATPARA, the drug’s manufacturer, Takeda, is working with the FDA to develop a Special Use Program. The program is intended to support patients previously prescribed NATPARA who are facing life-threatening complications as a result of discontinuation of NATPARA. Through this program, healthcare providers will be able...
Share

Trial & Error: When Study Results Disappoint

Researchers studied female anorexia nervosa patients to see whether testosterone could be a potential treatment. Despite promising results in previous trials, the current study’s outcomes were not as hoped. Anorexia nervosa (AN), a serious and potentially fatal eating disorder, affects up to 2% of women and carries with it a number of dangerous comorbidities, including...
Share

CEU Preview: Optimizing Testosterone Therapy for the Individual Patient

EN0719-CEU_cover-small In his talk, “Testosterone Replacement Modalities: Pros, Cons, and Their Correct Use,” Shehzad Sultan Basaria, MD, will discuss the benefits and drawbacks of various forms of treatments so clinicians can better inform their patients with hypogonadism. By now, the controversy surrounding testosterone therapy and the shady advertising schemes promulgating the idea of “andropause” in aging...